Insun Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Insun Choi has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Dong-Wan Chae
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
2 shared publications - Eunjeong Kang
Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
2 shared publications - Hajeong Lee
Transplantation Center, Seoul National University Hospital, Seoul, Republic of Korea
2 shared publications - Ho Jun Chin
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
2 shared publications - Hyo Jeong Kim
Division of Healthcare Technology Assessment Research, National Evidence-Based Healthcare Collaborating Agency, Seoul, Republic of Korea
2 shared publications - Jang-Hee Cho
Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (12)
Psychotropic Drug Use in Korean Patients With Osteoarthritis
Kang SH, et al. J Korean Med Sci. 2024 Dec;40:e53. https://doi.org/10.3346/jkms.2025.40.e53
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (12)
Open AccessPsychotropic Drug Use in Korean Patients With Osteoarthritis
Kang SH, et al. J Korean Med Sci. 2024 Dec;40:e53. https://doi.org/10.3346/jkms.2025.40.e53
- Open Access
- 31 January 2022
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 41 (1) , 102-113
Long-term risk of all-cause mortality in live kidney donors: a matched cohort study
Background: Long-term outcomes of live kidney donors remain controversial, although this information is crucial for selecting potential donors. Thus, this study compared the long-term risk of all-cause mortality between live kidney donors and healthy non-donors.Methods: We performed a retrospective cohort study including donors from seven tertiary hospitals in South Korea. Persons who underwent voluntary health screening were included as controls. We created a matched control group considering age, sex, era, body mass index, baseline hypertension, diabetes, estimated glomerular filtration rate, and dipstick albuminuria. The study outcome was progression to end-stage kidney disease (ESKD), and all-cause mortality as identified in the linked claims database. Results: We screened 1,878 kidney donors and 78,115 health screening examinees from 2003 to 2016. After matching, 1,701 persons remained in each group. The median age of the matched study subjects was 44 years, and 46.6% were male. Among the study subjects, 2.7% and 16.6% had underlying diabetes and hypertension, respectively. There were no ESKD events in the matched donor and control groups. There were 24 (1.4%) and 12 mortality cases (0.7%) in the matched donor and control groups, respectively. In the age-sex adjusted model, the risk for all-cause mortality was significantly higher in the donor group than in the control group. However, the significance was not retained after socioeconomic status was included as a covariate (adjusted hazard ratio, 1.82; 95% confidence interval, 0.87–3.80). Conclusion: All-cause mortality was similar in live kidney donors and matched non-donor healthy controls with similar health status and socioeconomic status in the Korean population.
- 31 January 2022
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 41 (1) , 102-113
Open AccessLong-term risk of all-cause mortality in live kidney donors: a matched cohort study
Background: Long-term outcomes of live kidney donors remain controversial, although this information is crucial for selecting potential donors. Thus, this study compared the long-term risk of all-cause mortality between live kidney donors and healthy non-donors.Methods: We performed a retrospective cohort study including donors from seven tertiary hospitals in South Korea. Persons who underwent voluntary health screening were included as controls. We created a matched control group considering age, sex, era, body mass index, baseline hypertension, diabetes, estimated glomerular filtration rate, and dipstick albuminuria. The study outcome was progression to end-stage kidney disease (ESKD), and all-cause mortality as identified in the linked claims database. Results: We screened 1,878 kidney donors and 78,115 health screening examinees from 2003 to 2016. After matching, 1,701 persons remained in each group. The median age of the matched study subjects was 44 years, and 46.6% were male. Among the study subjects, 2.7% and 16.6% had underlying diabetes and hypertension, respectively. There were no ESKD events in the matched donor and control groups. There were 24 (1.4%) and 12 mortality cases (0.7%) in the matched donor and control groups, respectively. In the age-sex adjusted model, the risk for all-cause mortality was significantly higher in the donor group than in the control group. However, the significance was not retained after socioeconomic status was included as a covariate (adjusted hazard ratio, 1.82; 95% confidence interval, 0.87–3.80). Conclusion: All-cause mortality was similar in live kidney donors and matched non-donor healthy controls with similar health status and socioeconomic status in the Korean population.
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (15) , e111
Hospice-Palliative Medicine as a Model of Value-Based Healthcare
Heo DS, et al. J Korean Med Sci. 2022 Apr;37(15):e111. https://doi.org/10.3346/jkms.2022.37.e111
- 1 January 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (15) , e111
Open AccessHospice-Palliative Medicine as a Model of Value-Based Healthcare
Heo DS, et al. J Korean Med Sci. 2022 Apr;37(15):e111. https://doi.org/10.3346/jkms.2022.37.e111
- Open Access
- 31 December 2021
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 40 (4) , 645-659
Metabolic risks in living kidney donors in South Korea
Considering the growing prevalence of Western lifestyles and related chronic diseases occurring in South Korea, this study aimed to explore the progression of metabolic risk factors in living kidney donors. This study enrolled living kidney donors from seven hospitals from 1982 to 2016. The controls were individuals that voluntarily received health check-ups from 1995 to 2016 that were matched with donors according to age, sex, diabetes status, baseline estimated glomerular filtration rate, and date of the medical record. Data on hyperuricemia, hypertension, hypercholesterolemia, and overweight/obesity were collected to determine metabolic risks. Logistic regressions with interaction terms between the medical record date and donor status were used to compare the trends in metabolic risks over time in the two groups. A total of 2,018 living kidney donors and matched non-donors were included. The median age was 44.0 years and 54.0% were women. The living kidney donors showed a lower absolute prevalence for all metabolic risk factors, except for those that were overweight/obese, than the non-donors. The proportion of subjects that were overweight/obese was consistently higher over time in the donor group. The changes over time in the prevalence of each metabolic risk were not significantly different between groups, except for a lower prevalence of metabolic risk factors ≥ 3 in donors. Over time, metabolic risks in living kidney donors are generally the same as in non-donors, except for a lower prevalence of metabolic risk factors ≥3 in donors.
- 31 December 2021
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 40 (4) , 645-659
Open AccessMetabolic risks in living kidney donors in South Korea
Considering the growing prevalence of Western lifestyles and related chronic diseases occurring in South Korea, this study aimed to explore the progression of metabolic risk factors in living kidney donors. This study enrolled living kidney donors from seven hospitals from 1982 to 2016. The controls were individuals that voluntarily received health check-ups from 1995 to 2016 that were matched with donors according to age, sex, diabetes status, baseline estimated glomerular filtration rate, and date of the medical record. Data on hyperuricemia, hypertension, hypercholesterolemia, and overweight/obesity were collected to determine metabolic risks. Logistic regressions with interaction terms between the medical record date and donor status were used to compare the trends in metabolic risks over time in the two groups. A total of 2,018 living kidney donors and matched non-donors were included. The median age was 44.0 years and 54.0% were women. The living kidney donors showed a lower absolute prevalence for all metabolic risk factors, except for those that were overweight/obese, than the non-donors. The proportion of subjects that were overweight/obese was consistently higher over time in the donor group. The changes over time in the prevalence of each metabolic risk were not significantly different between groups, except for a lower prevalence of metabolic risk factors ≥ 3 in donors. Over time, metabolic risks in living kidney donors are generally the same as in non-donors, except for a lower prevalence of metabolic risk factors ≥3 in donors.
- Open Access
- 16 July 2010
- Published by Wiley in Journal of Neurochemistry
- Vol. 114 (4) , 1085-1096
Compound K, a metabolite of ginsenosides, facilitates spontaneous GABA release onto CA3 pyramidal neurons
J. Neurochem.(2010)114, 1085–1096. Ginsenoside Rb1, a major ingredient of ginseng saponins, can affect various brain functions, including learning and memory. When ingested orally, ginsenoside Rb1 is not found in plasma as well as urine, but its metabolite compound K (ComK) reaches the systemic circulation in animals and human. Nevertheless, the pharmacological actions of ComK are still poorly known. In the present study, we investigated the effect of ComK on GABAergic spontaneous miniature inhibitory post‐synaptic currents (mIPSCs) in acutely isolated rat hippocampal CA3 pyramidal neurons using a conventional whole‐cell patch‐clamp technique. While ComK significantly increased mIPSC frequency in a concentration‐dependent manner, it had no effect on the current amplitude, suggesting that ComK acts pre‐synaptically to increase the probability of spontaneous GABA release. ComK still increased mIPSC frequency even in a Ca2+‐free external solution, suggesting that the ComK‐induced increase spontaneous GABA release is not related to Ca2+influx from the extracellular space. However, the ComK‐induced increase mIPSC frequency was significantly decreased after the blockade of either sarcoplasmic/endoplasmic reticulum Ca2+‐ATPase or Ca2+release channels. These results strongly suggest that ComK enhances spontaneous GABA release by increasing intraterminal Ca2+concentration via Ca2+release from pre‐synaptic Ca2+stores. The ComK‐induced modulation of inhibitory transmission onto CA3 pyramidal neurons could have a broad impact on the excitability of CA3 pyramidal neurons and affect the physiological functions mediated by the hippocampus.
- 16 July 2010
- Published by Wiley in Journal of Neurochemistry
- Vol. 114 (4) , 1085-1096
Open AccessCompound K, a metabolite of ginsenosides, facilitates spontaneous GABA release onto CA3 pyramidal neurons
J. Neurochem.(2010)114, 1085–1096. Ginsenoside Rb1, a major ingredient of ginseng saponins, can affect various brain functions, including learning and memory. When ingested orally, ginsenoside Rb1 is not found in plasma as well as urine, but its metabolite compound K (ComK) reaches the systemic circulation in animals and human. Nevertheless, the pharmacological actions of ComK are still poorly known. In the present study, we investigated the effect of ComK on GABAergic spontaneous miniature inhibitory post‐synaptic currents (mIPSCs) in acutely isolated rat hippocampal CA3 pyramidal neurons using a conventional whole‐cell patch‐clamp technique. While ComK significantly increased mIPSC frequency in a concentration‐dependent manner, it had no effect on the current amplitude, suggesting that ComK acts pre‐synaptically to increase the probability of spontaneous GABA release. ComK still increased mIPSC frequency even in a Ca2+‐free external solution, suggesting that the ComK‐induced increase spontaneous GABA release is not related to Ca2+influx from the extracellular space. However, the ComK‐induced increase mIPSC frequency was significantly decreased after the blockade of either sarcoplasmic/endoplasmic reticulum Ca2+‐ATPase or Ca2+release channels. These results strongly suggest that ComK enhances spontaneous GABA release by increasing intraterminal Ca2+concentration via Ca2+release from pre‐synaptic Ca2+stores. The ComK‐induced modulation of inhibitory transmission onto CA3 pyramidal neurons could have a broad impact on the excitability of CA3 pyramidal neurons and affect the physiological functions mediated by the hippocampus.